Common Human Leukocyte Antigen Alleles in Pemphigus Vulgaris and Pemphigus Foliaceus Italian Patients  by Lombardi, Maria Luisa et al.
Common Human Leukocyte Antigen Alleles in Pemphigus
Vulgaris and Pemphigus Foliaceus Italian Patients
Maria Luisa Lombardi, Ornella Mercuro, Vincenzo Ruocco,* Ada Lo Schiavo,*
Vincenza Lombari, Vincenzo Guerrera,* Giuseppe Pirozzi, and Ciro Manzo
Experimental Oncology C-Immunology, National Cancer Institute, Naples, Italy; *Department of Dermatology, 2nd University of Naples, Italy
Pemphigus refers to a group of autoimmune blistering
skin diseases, mainly identified as pemphigus vulgaris
and pemphigus foliaceus, both characterized by the
presence of autoantibodies against keratinocyte
adhesion molecules, leading to loss of cell–cell adhesion
with consequent blister formation. Pemphigus vulgaris
is reported to be associated with human leukocyte
antigen DR4 and/or DR6 whereas no data are available
on pemphigus foliaceus, except for the endemic
Brazilian form (fogo selvagem), which is reported to be
associated with DR1 and DR4. We here report human
leukocyte antigen molecular typing on a total of 87
patients, 61 with pemphigus vulgaris and 26 with
pemphigus foliaceus, versus 128 healthy matched con-
trols. Generic typing showed an increase of DRB1*04
and DRB1*14 and a decrease of DRB1*07 in both
pemphigus vulgaris and pemphigus foliaceus patients.
Molecular subtyping of DR4F and DR14F subjects
showed a highly significant association between the
DRB1*1401 and both pemphigus vulgaris (p < 0.0001)
and pemphigus foliaceus patients (p < 0.0001) together
with a significant increase of the linked DQB1*0503
The intraepidermal blistering autoimmune diseaseknown as pemphigus can be divided into two mainforms, vulgaris (PV) and foliaceus (PF), accordingto clinical, histologic, and immunologic features(Nousari and Anhalt, 1995). Both forms are charac-
terized by loss of epidermal cell–cell cohesion leading to acantholysis
and by the presence of pathogenic IgG autoantibodies directed
against cellular adhesion molecules desmoglein 3 (Dsg3) and
desmoglein 1 (Dsg1) (Stanley, 1989; Amagai et al, 1991; Karpati
et al, 1994), which have been identified as PV and PF antigens,
respectively (Stanley et al, 1984; Eyre and Stanley, 1988).
Genetic predisposition, found in several autoimmune diseases,
has been reported also for pemphigus, and the association between
human leukocyte antigen (HLA) class II genes and PV is well
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(pemphigus vulgaris p < 0.0001; pemphigus foliaceus
p < 0.0001). Moreover, whereas the association
between DRB1*0402 and pemphigus vulgaris (p <
0.0001) has been confirmed, no significant associa-
tion between a specific allele of the DR4 group
and pemphigus foliaceus, has been found. There-
fore, at least in Italian patients, pemphigus vulgaris
and pemphigus foliaceus share DRB1*1401 and
DQB1*0503, as susceptible human leukocyte antigen
alleles, whereas DRB1*0402 is only found associated
with pemphigus vulgaris. The observation that both
diseases, pemphigus vulgaris and pemphigus foliaceus,
carry the same susceptible human leukocyte antigen
alleles has been interpreted as a common genetic
background predisposing to pemphigus as, like in
other autoimmune disorders, it is not sufficient to
explain the onset of the disease on the basis of the sole
aforementioned alleles. Other linked genes and/or
environmental factors should play a facilitating role in
the outbreak of pemphigus, either pemphigus vulgaris
or pemphigus foliaceus. Key words: human leukocyte
antigen/pemphigus/polymerase chain reaction-sequence
specific primers typing. J Invest Dermatol 113:107–110, 1999
documented (Scharf et al, 1988; Ahmed et al, 1990, 1991). More-
over, molecular analysis of the HLA D region (DP, DQ, DR) has
revealed that PV–HLA class II gene association is more stringent
because of its correlation with particular allele specificities.
DRB1*0402 and/or DQB1*0503 in DR14 positive patients, are
the most frequent allele specificities reported in association with
PV in several ethnic groups (Niizeki et al, 1994; Carcassi et al,
1996; Delgado et al, 1996a; Lombardi et al, 1996). No data are
available on PF, except for the endemic Brazilian form, fogo selvagem,
which has been reported to be associated with DR1 and DR4
(Petzl-Erler and Santamaria, 1989; Moraes et al, 1991; Cerna et al,
1993; Moraes et al, 1997).
We previously reported a significant association between PV and
the alleles DRB1*0402, DRB1*1401, and DQB1*0503 in Italian
Caucasian, non-Jewish patients with a clear predominance of DR14
compared with DR4 (Lombardi et al, 1996). We here report for
the first time the molecular analysis of DRB1 and DQB1 alleles in
Italian Caucasian, non-Jewish patients affected by PF compared
with PV patients and healthy controls of the same geographic area.
MATERIALS AND METHODS
Patient and control population All patients and controls enrolled in
the study were of non-Jewish, strict Italian origin, from the southern
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Table I. DRB1 alleles frequency in PV and PF patients
compared with controls
PV patients (61) PF patients (26)
Controls (128)
DRB1* % % pa % p
01 11.7 8.1 – 11.5 –
15 9.3 8.1 – 3.8 –
16 7.8 4.9 – 11.5 –
03 13.3 8.1 – – –
04 15.6 34.4 5 0.04 34.6 5 0.33
11 54.6 37.7 – 38.4 –
12 0.8 – – – –
13 15.6 8.1 – 7.6 –
14 12.5 62.2 ,0.0001b 57.6 ,0.0001c
07 27.3 6.5 ,0.01 7.6 5 0.26
08 3.1 13.1 – 15.3 –
10 0.8 – – – –
aCorrected p values.
bp 5 5.5 3 10–11.
cp 5 3.0 3 10–5.
regions of the country. The diagnosis of PV or PF was based on clinical,
histologic, and immunologic data. In particular, histopathologic examination
of a skin lesion revealed suprabasal or subcorneal acantholysis in any PV
or PF specimen, respectively, and direct immunofluorescence studies
detected intercellular deposition of both IgG and C3 in the perilesional
epidermis of all patients.
HLA molecular typing Homozygous B lymphoblastoid cell lines from
the 10th International Histocompatibility Workshop were used as standard
in HLA molecular typing. Genomic DNA was prepared from peripheral
blood leukocytes by phenol extraction according to standard procedures.
Molecular analysis of DRB1 and DQB1 was carried out, as previously
described (Lombardi et al, 1998), either by the sequence-specific oligo-
nucleotide hybridization technique of polymerase chain reaction (PCR) -
amplified DNA (Kimura and Sasazuki, 1992) or by PCR–sequence-
specific primers (SSP) (Olerup and Zetterquist, 1992; Olerup et al, 1993).
Commercial kits (Dynal, Skøyen, Norway) for PCR–SSP low and high
resolution of DRB1 and DQB1 were used according to the manufacturer’s
instructions. Amplification was carried out by using Taq-polymerase-Gold
(Perkin Elmer, Foster City, CA). Molecular subtyping of DRB1*04 and
DRB1*14 positive patients and controls was performed using a PCR–SSP
method able to discriminate among the 25 different allele specificities of
the DRB1*04 and the 30 of the DRB1*14 group. DQB1 typing of
controls was also performed by the PCR–sequence-specific oligonucleotide
method according to the protocol of the 11th International Histocompat-
ibility Workshop (Kimura and Sasazuki, 1992). Locus-specific primers were
used for the DQB1 amplification and dot-blotted filters with amplified
DNA were hybridized with γ-32P-adenosine triphosphate-labeled probes.
Alleles were assigned according to the nomenclature for factors of the
HLA system (Bormer et al, 1997).
Statistical analysis p-values were calculated by the Fisher’s two-tailed
exact test. The corrected p-values were obtained by multiplying the p-
value for the number of measured alleles in each locus tested.
RESULTS
Analysis of DRB1 polymorphism by low resolution PCR–
SSP typing Molecular typing, using a low resolution PCR–SSP
method, has been carried out on 61 PV and only on 26 PF patients
because of the very low incidence of PF with respect to PV in the
Italian population. Data have been compared with 128 healthy
controls. Results, reported in Table I, showed a highly significant
increase of DRB1*14 in both groups of patients reaching 62.2%
in PV (p , 0.0001) and 57.6% in PF patients (p , 0.0001)
compared with 12.5% found in controls. Moreover, an increase of
DRB1*04, which reaches 34.4% in PV (p 5 0.04) and 34.6% in
PF patients (p 5 0.33) versus 15.6% found in controls, can be
noted. Therefore, as previously reported for PV, DR14 seems to
be the most represented specificity also in PF patients.
The frequency of other DRB1 alleles showed a nonsignificant
increase of DRB1*08 and a decrease of DRB1*07, the latter
Table II. DRB1 alleles frequency in DR4F PV and PF
patients compared with controlsa
PV patients (61) PF patients (26)
Controls (128)
DRB1* % % pb % p
0401 4.8 – – 3.8 –
0402 3.1 32.7 ,0.0001c 15.3 50.70
0403 3.1 1.6 – – –
0404 1.6 1.6 – – –
0405 1.6 – – 7.6 –
0407 0.8 – – 3.8 –
0408 0.8 – – 3.8 –
aNo controls or patients were positive for DRB1*0409–0425. One PV patients
was DRB1*0402,0403.
bCorrected p values.
cp 5 1.1 3 10–6.
Table III. DRB1 alleles frequency in DR141 PV and PF
patients compared with controlsa
PV patients (61) PF patients (26)
Controls (128)
DRB1* % % pb % p
1401 11.7 44.2 ,0.0001c 46.1 ,0.005
1404 0.8 16.3 ,0.01 11.5 50.45
1407 – 1.6 – – –
aNo controls or patients were positive for DRB1*1408–1430.
bCorrected p values.
cp 5 3.5 3 10–5.
present only in 6.5% of PV (p , 0.01) and in 7.6% of PF patients
(p 5 0.26) compared with the value of 27.3% found in the normal
population. It should be noted that, in both DR4 and DR14
positive patients, 96.6% of PV and 92.2% of PF subjects had an
associated antigen, seven of 61 PV and five of 26 PF patients did
not carry any associated antigen, and six PV and two PF patients
had both the DR4 and the DR14 antigens.
Analysis of DRB1*04 and DRB1*14 positive subjects by
high-resolution PCR–SSP typing As the most significant
difference, between patients and controls, was found in the fre-
quency of DRB1*04 and DRB1*14, all the subjects carrying these
alleles were subtyped by PCR–SSP high-resolution methods,
looking for a more stringent association with a particular allele
specificity. An interesting difference between PV and PF patients
emerged by comparing the subtyping of DRB1*041 subjects
(Table II). In fact, DRB1*0402 was found to be present in 20 of
21 DR41 PV patients and the difference compared with controls
was highly significant (p , 0.0001). Only four of nine DR41 PF
patients, on the contrary, showed the DRB1*0402 and the differ-
ence was not statistically significant (p 5 0.70). The remaining
DR41 PF patients showed a wide distribution of different allele
specificities as found in the DR41 control group. Uniformity of
results between PV and PF patients was, on the contrary, found
by analyzing the high-resolution subtyping of DR141 subjects
(Table III), which showed a highly significant increase of
DRB1*1401 both in PV (p , 0.0001) and in PF patients
(p , 0.005). Moreover, a significant increase of DRB1*1404 was
found in PV patients (p , 0.01), which should be confirmed on
a larger number of subjects because of the rare presence of this
allele in the normal population.
Analysis of DQB1 polymorphism by PCR–SSP high-reso-
lution typing Molecular analysis of DQB1 polymorphism is
reported in Table IV. The most striking difference between both
groups of patients and controls is the highly significant increase of
DQB1*0503 in linkage with DR14. It reaches 62.2% in PV
(p , 0.0001) and 57.6% in PF patients (p , 0.0001) with respect
to the frequency of 8.5% found in controls. Moreover, also
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Table IV. DQB1 alleles frequency in PV and PF patients
compared with controls
PV patients (61) PF patients (26)
Controls (128)
DQB1* % % pa % p
02 32.8 14.7 5 0.07 3.8 ,0.05
0301 57.8 47.5 – 46.1 –
0302 10.9 34.4 ,0.005 34.6 5 0.057
0303 2.3 – – 3.8 –
0402 1.6 8.1 – 11.5 –
0501 12.5 3.2 – 15.3 –
0502 9.3 6.5 – 11.5 –
0503 8.5 62.2 ,0.0001b 57.6 ,0.0001c
0601 5.4 1.6 – – –
0602 5.4 4.9 – 3.8 –
0603 6.2 – – – –
0604 10.9 8.1 – 3.8 –
aCorrected p values.
bp 5 1.8 3 10–12.
cp 5 1.2 3 10–6.
DQB1*0302, in linkage with DR4, is increased in both groups of
patients with values of 34.4% in PV (p , 0.005) and 34.6% in PF
patients (p 5 0.057) compared with the value of 10.9% found in
controls. Owing to the strong linkage between DR and DQ loci,
all the patients carrying the DRB1*14 had the DQB1*0503, as
well as all the patients carrying the DRB1*04 who had the
DQB1*0302. Moreover, the decrease of DQB1*02, found in both
diseases, is a consequence of the decrease of the linked DRB1*07.
HLA allele frequency and clinical features No association
between allelic frequencies and groups of patients, defined by
disease location, recurrence, antibody titre, and response to
immunosuppressive therapy was found. No significant differences
in clinical features were observed in PV or PF patients carrying
both DR4 and DR14 alleles. We have only observed that DR4
frequency in PV patients was 2.06 times higher in women (44.7%)
than in men (21.7%).
DISCUSSION
Several studies reported different HLA allele specificities associated
with PV in different ethnic groups (Scharf et al, 1988; Ahmed et al,
1990, 1991; Niizeki et al, 1994; Carcassi et al, 1996; Lombardi et al,
1996) whereas few data are available on HLA association and PF
except for the Brazilian form where DRB1*0102 (Moraes et al,
1991) and DRB1*01, 0404, 1402, and 1406 (Cerna et al, 1993;
Moraes et al, 1997) have been found in different racial groups.
We here report, for the first time, the molecular analysis of
DRB1 and DQB1 polymorphism in Italian patients affected by PF
comparing the data with those of PV patients and controls of the
same geographic area. The main result of the investigation has
been the demonstration of a highly significant association between
PF and the alleles DRB1*1401,and DQB1*0503, the same found
also for PV.
A decrease of DR7 together with the linked DQB1*02 and an
increase of DRB1*04 in both groups has been also noted, and
whereas molecular subtyping of DR41 patients showed a clear
association between DRB1*0402 and PV, no association between
any allele of the DR4 group and PF has been detected. A brief
communication on French patients confirms the above observation
reporting an increase of DR4 in both PV and PF, but DRB1*0402
was only found in PV patients (Le Cleach et al, 1997). Moreover
alleles of HLA DR4 (DRB1*0403,*0406) and DR14 groups
(DRB1*1401,*1405, 1406) have been found both in PF and PV
Japanese patients (Miyagawa et al, 1997).
A further consideration arising from the results is that DR4 and
the linked DRB1*0302 are both equally increased as the latter was
present in any patient carrying DR4 (Begovich et al, 1992). It is
difficult, of course, to assign a primary association with the DR or
with the DQ locus because the significant increase of DQB1*0302
could be only due to linkage disequilibrium. Only an analysis on
a larger number of PF patients comparing data of different ethnic
groups could give an insight to the question. Moreover, to clarify
better the role of DR and DQ alleles, functional studies on HLA
restricted T cell response should be extended also to PF because
when applied to PV, the T cell response against peptides derived
from Dsg3 appeared to be only restricted to HLA-DR and not to
DQ or DP (Lin et al, 1997).
The observation that patients with both diseases, PV and PF,
carry the same associated alleles (DRB1*1401, DQB1*0503)
deserves further consideration. It is possible that the sharing of
significant amino acid sequence homologies between the auto-
antigens Dsg3 and Dsg1 (Amagai, 1995) can give rise, as a
consequence, to a generation of peptides so similar as to bind the
same HLA allele. This hypothesis is supported by the observation
that peptides derived from Dsg3 can be selectively presented to T
cell clones by antigen-presenting cells that carry the DRB1*0402
or the DRB1*1401 (Wucherpfennig et al, 1995; Lin et al, 1997)
and, more interestingly, that T cells from some PF patients respond
to the same Dsg3 derived peptide (Lin et al, 1997). Furthermore,
the observation that patients with both forms of pemphigus, PV
and PF, carry the same susceptible HLA alleles can only be
interpreted as a common genetic background predisposing to
pemphigus. Other different factors could then determine both, the
onset and the clinical form of the disease. A similar sharing of HLA
alleles in different clinical forms of an immune blistering disorder
has already been reported between DQB1*0301 and three different
variants of bullous pemphigoid (Delgado et al, 1996b).
It is evident, therefore, that genetic predisposition is not able,
by itself, to explain the pathogenesis of these diseases. A demonstra-
tion of this may be the finding, in some pemphigus patients’ sera,
of autoantibodies that recognize both PV and PF antigens in
the presence of clinical manifestations typical of only one form
(Hashimoto et al, 1990; Amagai et al, 1996). Moreover, in the
serum of healthy relatives of PV patients low levels of non-
pathogenic, specific autoantibodies can be detected (Mohimen et al,
1993; Brandsen et al, 1997), and these autoantibodies have been
correlated with the presence, in the family group, of DR4 or DR6
antigens, which was the same found in PV patients (Ahmed et al,
1993). Disease can occur in susceptible individuals with low levels
of antibodies only when a second, different factor induces an
increase in antibody level sufficient to produce blisters (Ahmed
et al, 1993). This factor(s) can be either genetic or environmental as
drugs, burns, viruses, ultraviolet radiation and other heterogeneous
triggers (Chorzelski et al, 1971; Beutner and Chorzelski, 1976;
Ruocco et al, 1980; 1996; Ahmed and Rosen, 1989; Brenner et al,
1993; Cremniter et al, 1998; Tur and Brenner, 1998), proved to
be important in facilitating the outbreak of pemphigus.
In conclusion, although the etiology of pemphigus still remains
unknown, it appears that, like in other autoimmune diseases,
genetic predisposition is a condition necessary but not sufficient
for the onset of the disease which will develop only when one or
more additional factors intervene.
Dedicated to the memory of Dr. Ciro Manzo. The authors thank Dr. Ernesto de
Angelis (Experimental Oncology D-Pharmaco-Chemiotherapy, National Cancer
Institute, Napes, Italy) for his critical review of the manuscript. This work has been
partially supported by a grant from the Ministero della Sanita`, Ricerca Finalizzata
‘90 and by a grant from the Consiglio Nazionale delle Ricerche (CNR, 97-
04262-CT04).
REFERENCES
Ahmed AR, Rosen GB: Viruses in pemphigus. Int J Dermatol 28:209–217, 1989
Ahmed AR, Yunis EJ, Khatri K, et al: Major histocompatibility complex haplotype
studies in Ashkenazi Jewish patients with pemphigus vulgaris. Proc Natl Acad
Sci USA 87:7658–7662, 1990
110 LOMBARDI ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Ahmed AR, Wagner R, Khatri K, et al: Major histocompatibility complex haplotypes
and class II genes in non-Jewish patients with pemphigus vulgaris. Proc Natl
Acad Sci USA 88:5056–5060, 1991
Ahmed AR, Mohimen A, Yunis EJ, et al: Linkage of pemphigus vulgaris antibody
to the major histocompatibility complex in healthy relatives of patients. J Exp
Med 177:419–424, 1993
Amagai M: Adhesion molecules. I. Keratinocyte–keratinocyte interaction; cadherins
and pemphigus. J Invest Dermatol 104:146–152, 1995
Amagai M, Klaus-Kovtun V, Stanley JR: Autoantibodies against a novel epithelial
cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67:869–877, 1991
Amagai M, Koch PJ, Nishikawa T, Stanley JR: Pemphigus vulgaris antigen
(Desmoglein 3) is localized in the lower epidermis, the site of blister formation
in patients. J Invest Dermatol 106:351–355, 1996
Begovich AB, McClure GR, Suraj VC, et al: Polymorphism, recombination, and
linkage disequilibrium within the HLA class II region. J Immunol 148:249–
258, 1992
Beutner EH, Chorzelski TP: Studies on ethiological factors in pemphigus. J Cutan
Pathol 3:67–74, 1976
Bodmer JG, Marsh GE, Albert ED, et al: Nomenclature for factors of the HLA
system. Tissue Antigens 49 (297–320):1997
Brandsen R, Frusic Zlotkin M, Lyubimov H, et al: Circulating pemphigus IgG in
families of patients with pemphigus. Comparison of indirect
immunofluorescence, direct immunofluorescence and immunoblotting. J Am
Acad Dermatol 36:44–52, 1997
Brenner S, Wolf R, Ruocco V: Drug-induced pemphigus. I. A survey. Clin Dermatol
11:501–505, 1993
Carcassi C, Cottoni F, Floris L, et al: HLA haplotypes and class II molecular alleles
in Sardinian and Italian patients with pemphigus vulgaris. Tissue Antigens
48:662–667, 1996
Cerna M, Fernandez-Vina M, Friedman H, Moraes JR, Moraes ME, Diaz L, Stastny
P: Genetic markers for susceptibility to endemic Brazilian pemphigus foliaceus
(fogo selvagem) in Xavante indians. Tissue Antigens 47:138–140, 1993
Chorzelski TP, Jablonska S, Beutner EH, Kowalska M: Can pemphigus be provoked
by burn? Br J Dermatol 85:320–325, 1971
Cremniter D, Baudin M, Roujeau JC, Prost C: Stressful life events as potential
triggers of pemphigus. Arch Dermatol 134:1486–1487, 1998
Delgado JC, Yunis DE, Bozon MV, et al: MHC class II alleles and haplotype in
patients with pemphigus vulgaris from India. Tissue Antigens 48:668–672, 1996a
Delgado JC, Turbay D, Yunis EJ, et al: A common major histocompatibility complex
class II allele HLA-DQB1*0301 is present in clinical variant of pemphigoid.
Proc Natl Acad Sci USA 93:8569–8571, 1996b
Eyre RW, Stanley JR: Identification of pemphigus vulgaris antigen extracted from
normal human epidermis and comparison with pemphigus foliaceus antigen. J
Clin Invest 81:807–812, 1988
Hashimoto T, Ogawa MM, Konohana A, Nishikawa T: Detection of pemphigus
vulgaris and pemphigus foliaceus antigens by immunoblot analysis using
different antigen sources. J Invest Dermatol 94:327–331, 1990
Karpati S, Amagai M, Prussick R, Stanley JR: Pemphigus vulgaris antigen is a
desmosomal desmoglein. Dermatol 189 (Suppl. 1):24–26, 1994
Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference
protocol for the HLA DNA typing technique. In: Tsuji K, Aizawa M, Sasazuki
T (eds). Oxford: Oxford University Press, 1992, pp 397–419
Le Cleach L, Loiseau P, Lepage V, et al: HLA de class II et susceptibilite` au Pemphigus
vulgaire et superficiel en France. Ann Dermatol Venereol 124 (Suppl. 1):S30, 1997
Lin MS, Swartz SJ, Lopez A, et al: Development and characterization of Desmoglein-
3 specific T cell from patients with pemphigus vulgaris. J Clin Invest 99:31–
40, 1997
Lombardi ML, Mercuro O, Tecame G, et al: Molecular analysis of HLA DRB1 and
DQB1 in Italian patients with pemphigus vulgaris. Tissue Antigens 47:228–
230, 1996
Lombardi ML, Mercuro O, Pirozzi G, Ionna F, Mozzillo N, Manzo C: Molecular
analysis of HLA DRB1 and DQB1 polymorphism in Italian melanoma patients.
J Immunotherapy 21:435–439, 1998
Miyagawa S, Higashimine I, Iida T, Yamashina Y, Fukumoto T, Shirai T: HLA
DRB1*04 and DRB1*14 alleles are associated with susceptibility to pemphigus
among Japanese. J Invest Dermatol 109:615–618, 1997
Mohimen A, Narula M, Ruocco V, Pisani M, Ahmed AR: Presence of the
autoantibody in healthy relatives of Italian patients with pemphigus vulgaris.
Arch Dermatol Res 285:176–177, 1993
Moraes JR, Moraes EM, Fernandez-Vina M, et al: HLA antigens and risk for
development of pemphigus foliaceus (fogo selvagem) in endemic areas of
Brazil. Tissue Antigens 33:388–391, 1991
Moraes ME, Fernandez-Vina M, Lazaro A, et al: An epitope in the third hypervariable
region of the DRB1 gene is involved in the susceptibility to endemic pemphigus
foliaceus (fogo selvagem) in three different Brazilian population. Tissue Antigens
49:35–40, 1997
Niizeki H, Inoko N, Mizuki N, et al: HLA-DQA1-DQB1 and DRB1genotyping
in Japanese pemphigus vulgaris patients by the PCR-RFLP method. Tissue
Antigens 44:248–251, 1994
Nousari HC, Anhalt GJ: Bullous skin diseases. Curr Opin Immunol 7:844–852, 1995
Olerup O, Zetterquist H: HLA-DR typing by PCR amplification with sequence
specific primers (PCR–SSP) in 2 hours. An alternative to serological DR
typing in clinical practice including donor-recipient matching in cadaveric
transplantation. Tissue Antigens 39:225–235, 1992
Olerup O, Aldener A, Fogdell A: HLA-DQB1 and DQA1 typing by PCR
amplification with sequence specific primers (PCR–SSP) in 2 hours. Tissue
Antigens 41:119–134, 1993
Petzl-Erler ML, Santamaria J: Are HLA class II genes controlling susceptibility and
resistance to Brazilian pemphigus foliaceus (fogo selvagem)? Tissue Antigens
33:408–414, 1989
Ruocco V, Vitale O, Astarita C: Transient pemphigus induced by sunburn. J Cutan
Pathol 7:429–430, 1980
Ruocco V, Wolf R, Ruocco E, Baroni A: Viruses in pemphigus: a casual or causal
relationship? Int J Dermatol 35:782–784, 1996
Scharf SJ, Friedmann A, Brautbar C, et al: HLA class II allelic variation and
susceptibility to pemphigus vulgaris. Proc Natl Acad Sci USA 85:3504–3508, 1988
Stanley JR: Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-
mediated diseases. J Clin Invest 83:1443–1448, 1989
Stanley JR, Koulu L, Thivolet C: Distinction between epidermal antigens binding
pemphigus vulgaris and pemphigus foliaceus autoantibodies. J Clin Invest
74:313–320, 1984
Tur E, Brenner S: Diet and pemphigus. In pursuit of exogenous factors in pemphigus
and fogo selvagem. Arch Dermatol 134:1406–1410, 1998
Wucherpfennig KW, Yu B, Bhol K, et al: Structural basis for major histocompatibility
complex (MHC) -linked susceptibility to autoimmunity: Charged residues of
a single MHC pocket confer selective presentation of self-peptides in pemphigus
vulgaris. Proc Natl Acad Sci USA 92:11935–11939, 1995
